Corticosteroid-induced bone loss in men

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 3, 1998, Pages 801-806

  Pearce, Georgina ^a   Tabensky, D Aaron ^a   Delmas, Pierre D ^c   Baker, H W Gordon ^b   Seeman, Ego ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOSTEROID; GROWTH HORMONE; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISOLONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; SPERM ANTIBODY; TESTOSTERONE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; FEMUR NECK; HUMAN; INFERTILITY; LUMBAR SPINE; MALE; MALE INFERTILITY; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; STEROID THERAPY;

EID: 0031787349     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.3.4621     Document Type: Article

References (34)

1. Dempster DW, Arlot MA, Meunier PJ. 1983 Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int. 35:410-417.
2. Stellon AJ, Webb A, Compston JE. 1988 Bone histomorphomerry and structure in corticosteroid treated chronic active hepatitis. Gut. 29:378-384.
3. Prummel MF, Wiersinga WM, Lips P, et al. 1991 The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab. 72:382-386.
4. Hall GM, Spector TD, Delmas PD. 1995 Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 38:902-906.
5. 3. Clin Orthop. 181:264-268.
6. Crilly R, Marshall DH, Cawood M, Nordin BEC. 1978 Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women. Proc R Soc Med. 71:733-736.
7. Gourmelen M, Girard F, Binoux M. 1982 Serum somatomedin/insulin like growth factor (IGF) and IGF carrier levels in patients with cushing's syndrome or receiving glucocortocoid therapy. J Clin Endocrinol Metab. 54:885-892.
8. Frantz AG, Rabkin MT. 1964 Human growth hormone. N Engl J Med. 271:1376-1381.
9. Paz-Pacheco E, Fuleihan GE, Leboff MS. 1995 Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. J Bone Miner Res. 10:1713-1718.
10. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. 1979 Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D adminsrration. J Clin Invest. 64:655-665.
11. Gennari C, Imbimbo B, Montagnani M, Bernini M, et al. 1984 Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int. 36:245-252.
12. Pearce G, Ryan PFJ, Delmas PD, Tabensky A, Seeman E. The deleterious effect of low dose corticosteroids on bone density and bone turnover: a prospective study in patients with Polymyaliga Rheumatica. Br J Rheumatol. In press.
13. Hattersley AT, Meeran K, Burrun J, et al. 1994 The effect of long-term and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcif Tissue Int. 54:198-202.
14. Baker HWG, Clarke GN, Hudson B, et al. 1983 Treatment of sperm autoimmunity in men. Clin Reprod Fertil. 2:55-71.
15. Hendy WF, Hughes L, Scammell G, Pryor JP, Hargreave TB. 1990 Comparison of prednisolone and placebe in subfertile men with antibodies to spermatozoa. Lancet. 335:85-88.
16. Mazess RB, Wahner HM. 1988 Nuclear medicine and densitometry. In: Riggs BL, Melton III LJ, eds. Osteoporosis, aetiology, diagnosis, and management. New York: Raven Press; 251-295.
17. Garnero P, Grimaux M, Demiaux B, et al. 1992 Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res. 7:1389-1397.
18. Garnero P, Delmas PD. 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometic assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 77:1046-1053.
19. Winterbottom N, Vernon S, Freeman K, Dankoff G, Sevedin S. 1993 A serum immunoassay for the C-Terminal propeptide of type 1 collagen. J Bone Miner Res. 8(Suppl 1):S341.
20. Garnero P, Gineyts E, Riou PR, Delmas PD. 1994 Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab. 79:780-785.
21. Mazess R. 1982 On ageing bone loss. Clin Orthop. 165:239-252.
22. Hui SL, Slemenda CW, Johnston CCJr. 1988 Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 81:1804-1809.
23. Nielsen HK, Thomsen K, Eriksen EF, et al. 1988 The effect of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner. 4:105-113.
24. Godschalk MF, Downs RW. 1988 Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res. 3:113-115.
25. Hahn TJ, Halstead LR, Baran, DT. 1981 Effects of short term glucocorticoid administration on intestinal calcium absortion and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 52:111-115.
26. Reid IR, Ibbertson HK, France JT, Pybus J. 1985 Plasma testosterone concentrations in asthmatic men treated with glucocorticoids. Br Med J. 291:574.
27. Morrison D, Capewell S, Reynolds SP, et al. 1994 Testosterone levels during systemic and inhaled corticosteroid therapy. Respir Med. 88:659-663.
28. MacAdams MR, White RH, Chipps BE. 1986 Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med. 104:648-651.
29. Martens HF, Sheets PK, Tenover JS, Dugowson CE, Bremner WJ, Starkebaum G. 1994 Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisolone therapy. Br J Rheumatol. 21:1427-1431.
30. Doerr P, Pirke KM. 1976 Cortisol-induced suppression of plasma testosterone in normal adult males. J Clin Endocrinol Metab. 43:662-629.
31. Mateo L, Nolla JM, Bonnin MA, Navarro MA, Roid-Escofet D. 1995 Sex hormome status and bone mineral density in men with rheumatoid athritis. J Rheumatol. 22:1455-1460.
32. Praet J-P, Peretz A, Sozenberg S, Famey J-F, Bourdoux P. 1992 Risk of osteoporosis in men with chronic bronchitis. Osteop Int. 2:257-261.
33. Miell JP, Buchanan CR, Norman MR, Maheshwari HG, Blum WF. 1994 The evolution of changes in immunreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. J Bone Miner Res. 142:547-554.
34. Casanueva FF, Burguera B, Muruais C, Dieguez C. 1990 Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab. 70:234-237.